4.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:百万円) |
| 前連結会計年度 (2025年3月31日) | 当連結会計年度 (2026年3月31日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 87,064 | 88,364 |
受取手形、売掛金及び契約資産 | 59,238 | 74,776 |
電子記録債権 | 3,561 | 3,731 |
商品及び製品 | 28,419 | 32,293 |
仕掛品 | 6,722 | 8,153 |
原材料及び貯蔵品 | 22,185 | 23,880 |
その他 | 4,992 | 5,881 |
貸倒引当金 | △206 | △254 |
流動資産合計 | 211,978 | 236,825 |
固定資産 | | |
有形固定資産 | | |
建物及び構築物 | 85,849 | 105,496 |
減価償却累計額 | △57,365 | △71,110 |
建物及び構築物(純額) | 28,483 | 34,386 |
機械装置及び運搬具 | 116,620 | 127,822 |
減価償却累計額 | △99,468 | △104,164 |
機械装置及び運搬具(純額) | 17,151 | 23,658 |
土地 | 20,343 | 20,645 |
リース資産 | 573 | 504 |
減価償却累計額 | △495 | △122 |
リース資産(純額) | 77 | 382 |
建設仮勘定 | 15,854 | 13,776 |
その他 | 18,856 | 20,400 |
減価償却累計額 | △15,698 | △16,522 |
その他(純額) | 3,157 | 3,878 |
有形固定資産合計 | 85,069 | 96,726 |
無形固定資産 | | |
その他 | 1,950 | 1,918 |
無形固定資産合計 | 1,950 | 1,918 |
投資その他の資産 | | |
投資有価証券 | 41,864 | 46,086 |
長期貸付金 | 8 | 6 |
繰延税金資産 | 1,212 | 1,159 |
退職給付に係る資産 | 9,557 | 13,054 |
その他 | 5,707 | 3,459 |
貸倒引当金 | △151 | △70 |
投資その他の資産合計 | 58,198 | 63,697 |
固定資産合計 | 145,218 | 162,343 |
資産合計 | 357,196 | 399,168 |
| | (単位:百万円) |
| 前連結会計年度 (2025年3月31日) | 当連結会計年度 (2026年3月31日) |
負債の部 | | |
流動負債 | | |
支払手形及び買掛金 | 22,305 | 21,429 |
電子記録債務 | 1,580 | 493 |
短期借入金 | 1,490 | 1,341 |
1年内返済予定の長期借入金 | 816 | 1,013 |
リース債務 | 254 | 269 |
未払費用 | 1,904 | 2,017 |
未払法人税等 | 7,682 | 14,690 |
預り金 | 4,328 | 4,585 |
賞与引当金 | 3,915 | 4,163 |
資産除去債務 | 174 | 109 |
その他 | 13,871 | 36,127 |
流動負債合計 | 58,325 | 86,241 |
固定負債 | | |
長期借入金 | 2,008 | 1,961 |
リース債務 | 473 | 555 |
繰延税金負債 | 11,561 | 9,581 |
執行役員退職慰労引当金 | 8 | 6 |
退職給付に係る負債 | 4,976 | 3,404 |
資産除去債務 | 22 | 23 |
その他 | 269 | 929 |
固定負債合計 | 19,321 | 16,461 |
負債合計 | 77,646 | 102,703 |
純資産の部 | | |
株主資本 | | |
資本金 | 17,742 | 17,742 |
資本剰余金 | 15,058 | 15,058 |
利益剰余金 | 220,195 | 249,159 |
自己株式 | △6,271 | △26,276 |
株主資本合計 | 246,724 | 255,683 |
その他の包括利益累計額 | | |
その他有価証券評価差額金 | 21,072 | 25,271 |
為替換算調整勘定 | 6,437 | 7,973 |
退職給付に係る調整累計額 | 4,294 | 6,417 |
その他の包括利益累計額合計 | 31,803 | 39,662 |
非支配株主持分 | 1,022 | 1,119 |
純資産合計 | 279,550 | 296,465 |
負債純資産合計 | 357,196 | 399,168 |
E0088044030日油株式会社NOF CORPORATION通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-04-012026-03-31FY2026-03-312024-04-012025-03-312025-03-311falsefalsefalse440302025-03-31tse-acedjpfr-44030:FunctionalChemicalsReportableSegmentMember440302025-03-31tse-acedjpfr-44030:PharmaceuticalsMedicalsAndHealthReportableSegmentsMember440302025-03-31tse-acedjpfr-44030:ExplosiveAndPropulsionReportableSegmentMember440302024-04-012025-03-31tse-acedjpfr-44030:FunctionalChemicalsReportableSegmentMember440302024-04-012025-03-31tse-acedjpfr-44030:PharmaceuticalsMedicalsAndHealthReportableSegmentsMember440302024-04-012025-03-31tse-acedjpfr-44030:ExplosiveAndPropulsionReportableSegmentMember440302026-03-31jpcrp_cor:TotalOfReportableSegmentsAndOthersMember440302026-03-31jpcrp_cor:ReconcilingItemsMember440302025-04-012026-03-31jpcrp_cor:TotalOfReportableSegmentsAndOthersMember440302025-04-012026-03-31jpcrp_cor:ReconcilingItemsMember440302025-03-31jpcrp_cor:TotalOfReportableSegmentsAndOthersMember440302025-03-31jpcrp_cor:ReconcilingItemsMember440302024-04-012025-03-31jpcrp_cor:TotalOfReportableSegmentsAndOthersMember440302024-04-012025-03-31jpcrp_cor:ReconcilingItemsMember440302026-03-31jpcrp_cor:ReportableSegmentsMember440302026-03-31jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember440302025-04-012026-03-31jpcrp_cor:ReportableSegmentsMember440302025-04-012026-03-31jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember440302025-03-31jpcrp_cor:ReportableSegmentsMember440302025-03-31jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember440302024-04-012025-03-31jpcrp_cor:ReportableSegmentsMember440302024-04-012025-03-31jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember440302026-03-31tse-acedjpfr-44030:FunctionalChemicalsReportableSegmentMember440302026-03-31tse-acedjpfr-44030:PharmaceuticalsMedicalsAndHealthReportableSegmentsMember440302026-03-31tse-acedjpfr-44030:ExplosiveAndPropulsionReportableSegmentMember440302025-04-012026-03-31tse-acedjpfr-44030:FunctionalChemicalsReportableSegmentMember440302025-04-012026-03-31tse-acedjpfr-44030:PharmaceuticalsMedicalsAndHealthReportableSegmentsMember440302025-04-012026-03-31tse-acedjpfr-44030:ExplosiveAndPropulsionReportableSegmentMember440302024-04-012025-03-31jppfs_cor:TreasuryStockMember440302024-04-012025-03-31jppfs_cor:ShareholdersEquityMember440302024-04-012025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember440302024-04-012025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember440302024-04-012025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember440302024-04-012025-03-31jppfs_cor:NonControllingInterestsMember440302024-04-012025-03-31jppfs_cor:CapitalStockMember440302025-03-31jppfs_cor:CapitalStockMember440302025-03-31jppfs_cor:CapitalSurplusMember440302025-03-31jppfs_cor:RetainedEarningsMember440302025-03-31jppfs_cor:TreasuryStockMember440302025-03-31jppfs_cor:ShareholdersEquityMember440302025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember440302025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember440302025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember440302025-03-31jppfs_cor:NonControllingInterestsMember440302026-03-31440302025-04-012026-03-31440302025-03-31440302024-03-31440302024-04-012025-03-31440302026-05-11440302024-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember440302024-04-012025-03-31jppfs_cor:RetainedEarningsMember440302025-04-012026-03-31jppfs_cor:NonControllingInterestsMember440302026-03-31jppfs_cor:ShareholdersEquityMember440302026-03-31jppfs_cor:CapitalStockMember440302026-03-31jppfs_cor:CapitalSurplusMember440302026-03-31jppfs_cor:RetainedEarningsMember440302026-03-31jppfs_cor:TreasuryStockMember440302026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember440302026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember440302026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember440302026-03-31jppfs_cor:NonControllingInterestsMember440302025-04-012026-03-31jppfs_cor:ShareholdersEquityMember440302025-04-012026-03-31jppfs_cor:CapitalStockMember440302025-04-012026-03-31jppfs_cor:CapitalSurplusMember440302025-04-012026-03-31jppfs_cor:RetainedEarningsMember440302025-04-012026-03-31jppfs_cor:TreasuryStockMember440302025-04-012026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember440302025-04-012026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember440302025-04-012026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember440302024-03-31jppfs_cor:CapitalStockMember440302024-03-31jppfs_cor:CapitalSurplusMember440302024-03-31jppfs_cor:RetainedEarningsMember440302024-03-31jppfs_cor:TreasuryStockMember440302024-03-31jppfs_cor:ShareholdersEquityMember440302024-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember440302024-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember440302024-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember440302024-03-31jppfs_cor:NonControllingInterestsMember440302024-04-012025-03-31jppfs_cor:CapitalSurplusMember440302026-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember440302025-04-012026-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember440302025-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember440302024-04-012025-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMemberxbrli:pureiso4217:JPY